Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 65.06
   
  • Change Today:
    $1.50
  • 52 Week High: $87.29
  • 52 Week Low: $62.71
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 9,793,590
  • Market Cap: $81,065m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Gilead raises 2020 forecasts after Covid-19 surge boosts remdesivir

By Abigail Townsend

Date: Monday 11 Jan 2021

(Sharecast News) - Gilead Sciences has upped its full-year profit guidance following strong sales of its Covid-19 treatment remdesivir.

FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir

By Alexander Bueso

Date: Friday 20 Nov 2020

(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.

WHO advises against prescribing remdesivir for C... 20-Nov-2020 ShareCast
Eli Lilly halts late stage trial into Covid-19 a... 27-Oct-2020 ShareCast
FDA grants full approval to Gilead Sciences's Ve... 23-Oct-2020 ShareCast
Gilead Sciences's Remdesivir may cut Covid-19 ri... 10-Jul-2020 ShareCast
Single course of Covid-19 treatment to cost $2,3... 29-Jun-2020 ShareCast
Gilead Sciences to test inhaled version of Covid... 22-Jun-2020 ShareCast
JP Morgan stays at overweight on AstraZeneca fol... 08-Jun-2020 ShareCast
AstraZeneca approached Gilead about merger - rep... 08-Jun-2020 ShareCast
Sunday newspaper round-up: Pandemic, Jobs, Astra... 07-Jun-2020 ShareCast
Japan approves Gilead Sciences's Remdesivir for ... 07-May-2020 ShareCast
Top US expert hails 'quite good news' on Gilead ... 29-Apr-2020 ShareCast
Gilead Sciences shares halted after 'positive da... 29-Apr-2020 ShareCast
RBC Capital labels news on Gilead Science's Remd... 17-Apr-2020 ShareCast
Europe midday: Stocks snap back amid optimism fo... 17-Apr-2020 ShareCast
Gilead treatment has positive results on Covid-1... 17-Apr-2020 ShareCast
Gilead Sciences acquires immuno-oncology firm Fo... 02-Mar-2020 ShareCast
GSK and Gilead Sciences join race to find corona... 03-Feb-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 65.06
Change Today $ 1.50
% Change 2.36 %
52 Week High $87.29
52 Week Low $62.71
Volume 9,793,590
Shares Issued 1,246.00m
Market Cap $81,065m
RiskGrade 120

What The Brokers Say

Strong Buy 4
Buy 8
Neutral 17
Sell 1
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 400 @ $65.07
15:59 300 @ $65.07
15:59 200 @ $65.07
15:59 300 @ $65.07
15:59 100 @ $65.07

Top of Page